Tirzepatide 15mg
A more deliberate approach to metabolic health.
A once-weekly protocol built around your consultation, positioned within the Metabolic pathway.
Assessment required before purchase.
Check Eligibility →Free to start. Your pathway and pricing are confirmed after a short wellness assessment.
What is Tirzepatide?
Tirzepatide is a once-weekly medication that activates two naturally occurring hormone pathways, GIP and GLP-1, both involved in appetite regulation and glucose metabolism. It's one of the most extensively studied newer therapies in metabolic health.
Effects build gradually rather than on a fixed timeline — clinical studies have followed outcomes over many months, with individual response varying from person to person. Treatment may continue long-term when it's clinically appropriate, with dose adjusted along the way based on response and tolerability.
Suitability depends on your health history, goals, and other clinical factors. YRT begins with an assessment so the right pathway can be confirmed with clinical guidance — not assumed from a product page.
Why this protocol
This protocol belongs to the Metabolic pathway. Your consultation identifies whether it's the right step for your journey.
Your YRT Kit
- 01Wellness Protocol
- 02Bacteriostatic Water
- 03Protocol Pouch
- 04Premium 31G Syringes
- 05BD Alcohol Swabs
- 06Companion Card
Details
- Storage
- Refrigerated at 2–8°C, protected from light.
- Preparation
- Preparation requirements depend on the formulation supplied and the instructions provided with your yrt pathway. If your product requires reconstitution, use only the supplied materials and follow the preparation instructions provided by your healthcare professional. Do not alter the concentration, combine products, or change the prescribed dose without clinical guidance.
- Common effects
- Gastrointestinal effects including nausea, diarrhea, decreased appetite, vomiting, constipation, indigestion and abdominal pain are among the commonly reported reactions.
- Please note
- Educational content pending clinical review. This is not medical advice.